MedPath

OrthoEvidence Trial Assessing Japanese Knowledge Updates

Not Applicable
Completed
Conditions
Healthy Volunteer
Interventions
Other: English evidence summaries (Advanced Clinical Evidence report from OrthoEvidence)
Other: Japanese-translated evidence summaries (Advanced Clinical Evidence report from OrthoEvidence)
Registration Number
NCT05250622
Lead Sponsor
McMaster University
Brief Summary

The purpose of this randomized controlled trial is to clarify whether providing translated evidence summary (Advanced Clinical Evidence (ACE) reports from OrthoEvidence) will increase the access to the summary compared to providing the original version of evidence summary among Japanese orthopaedic surgeons

Detailed Description

The investigators will conduct the survey regarding baseline characteristics, barriers and familiality to evidence-based medicine by online. After the survey, the participants will be randomly assigned to receive either the original version of ACE reports or Japanese version of ACE reports. The pdf of each ACE report will be provided to the participants through an email link. Twenty reports will be sent over 4 weeks period. After that, the investigators will conduct another survey regarding the reports.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
105
Inclusion Criteria
  1. Member of Japanese Society for Fracture Repair (JSFR)
  2. Spend at least 20% of their time in clinical practice
  3. Non-native speaker of English
  4. Has regular access to internet
  5. Prefer to read Japanese-translated material, if there are both translated and English version of the same material.
Exclusion Criteria

We will exclude surgeons who cannot provide informed consent.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
English groupEnglish evidence summaries (Advanced Clinical Evidence report from OrthoEvidence)Participants who will receive English version of evidence summaries
Japanese groupJapanese-translated evidence summaries (Advanced Clinical Evidence report from OrthoEvidence)Participants who will receive Japanese-translated version of evidence summaries
Primary Outcome Measures
NameTimeMethod
Number of access to evidence summariesFour weeks (28 days) after the commencement of the trial

Total number of access to evidence summaries

Secondary Outcome Measures
NameTimeMethod
Self-rated score of understanding the contents of the provided materialsWithin four weeks after the end of intervention

Five-point Likert scale in understanding the contents of provided materials, evaluated by the participants (higher scores means better outcome)

Self-rated score in changing their practice based on the contents of the materialsWithin four weeks after the end of intervention

Five-point Likert scale in changing their practice based on the contents of the materials evaluated by the participants (higher scores means better outcome)

Trial Locations

Locations (1)

McMaster University

🇨🇦

Hamilton, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath